Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123910332 | 12391033 | 2 | F | 201603 | 20160722 | 20160520 | 20160727 | EXP | US-PFIZER INC-2016266667 | PFIZER | 69.00 | YR | F | Y | 107.00000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123910332 | 12391033 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Z995L | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 123910332 | 12391033 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 123910332 | 12391033 | 3 | C | CALCIUM CITRATE WITH VITAMIN D3 AND K | 2 | Oral | 1 DF, 2X/DAY | 0 | 1 | DF | TABLET | BID | |||||||
| 123910332 | 12391033 | 4 | C | GLUSAMINE | 2 | Oral | 1500 MG, 2X/DAY | 0 | 1500 | MG | TABLET | BID | |||||||
| 123910332 | 12391033 | 5 | C | CLONIDINE. | CLONIDINE | 1 | Oral | 0.1 MG, 2X/DAY | 0 | .1 | MG | TABLET | BID | ||||||
| 123910332 | 12391033 | 6 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 120 MG, DAILY | 0 | 120 | MG | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123910332 | 12391033 | 1 | Breast cancer |
| 123910332 | 12391033 | 2 | Blood cholesterol increased |
| 123910332 | 12391033 | 4 | Bone development abnormal |
| 123910332 | 12391033 | 5 | Hypertension |
| 123910332 | 12391033 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123910332 | 12391033 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123910332 | 12391033 | Bronchitis | |
| 123910332 | 12391033 | Cough | |
| 123910332 | 12391033 | Laryngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123910332 | 12391033 | 1 | 2014 | 0 | ||
| 123910332 | 12391033 | 5 | 20160405 | 0 | ||
| 123910332 | 12391033 | 6 | 20160405 | 0 |